Steve Kirsch, founder of the COVID-19 Early Treatment Fund (CETF) discussed the evidence backing fluvoxamine as a treatment for COVID-19. … Quality journalism costs money to…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.